Harald Pedersen (engineer)
From Wikipedia, the free encyclopedia
1878
Harald Pedersen | |
|---|---|
| Born | Peter Harald Pedersen 1878 Øster Hurup, Denmark |
| Died | 1966 (aged 87–88) Denmark |
| Occupation(s) | Engineer, industrialist |
| Known for | Co-founder of Novo Terapeutisk Laboratorium, today Novo Nordisk |
Harald Pedersen (born 1878 in Øster Hurup – died 1966) was a Danish engineer and industrialist who, together with his brother Thorvald Pedersen, co-founded the pharmaceutical company Novo Terapeutisk Laboratorium in 1925, predecessor of Novo Nordisk. Their work played a key role in the early Danish insulin industry.[1]
Harald Pedersen was born in Øster Hurup, Denmark, in 1878. He began his working life as an apprentice blacksmith at age 15. He later worked as an engineer at Frederiksberg Electricity Works until 1918, when after a workplace accident in which he lost an eye, he left that employment and became manager of the mechanical workshop at the Laboratory of Zoophysiology, University of Copenhagen.[1][2]
Career
In the early 1920s, Harald Pedersen worked with Nobel laureate August Krogh (and others) at the Laboratory of Zoophysiology; his mechanical workshop produced machines used in early insulin production.[3][4]
In autumn 1923, his brother Thorvald was hired by Nordisk Insulinlaboratorium to analyse chemical processes in insulin production; Harald also worked at Nordisk.[5]
Founding of Novo Terapeutisk Laboratorium
In 1924 a dispute occurred at Nordisk: Thorvald was fired by Hans Christian Hagedorn, co-founder of Nordisk, and Harald resigned in solidarity.[1] In February 1925 the brothers formally founded Novo Terapeutisk Laboratorium.[4] The company developed a dedicated insulin production facility and a specialty injection device (the "Novo Syringe").[5]
Work
- Development of dedicated machinery for insulin extraction and purification at the Zoophysiology Laboratory workshop.[3]
- Design and implementation of early insulin delivery technologies (the "Novo Syringe" for self-injection).[5]
- Co-development of Insulin Novo, marketed by Novo Terapeutisk in the mid-1920s.[4]